Announced
Completed
NXTHERA INC / BOSTON SCIENTIFIC CORPORATION / Acquisition / Private
Financials
Transaction Value-
Consideration Type-
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
medical devices
Medical Equipment
Private
Acquisition
Completed
Friendly
Single Bidder
United States
Synopsis
Acquisition by Boston Scientific of NxThera, a developer of the Rezum® system, a minimally invasive treatment options for men with symptoms arising from of benign prostatic hyperplasia (BPH).
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.